Clinical Trials on PPH in United Kingdom

Total 136 results

Andrew Weeks MD MRCOG
National Institute for Health Research, United Kingdom; Liverpool Women's NHS...

Completed

The Postpartum Haemorrhage (PPH) Butterfly Work Package 3

Postpartum Haemorrhage (PPH)

United Kingdom
PROCEPT BioRobotics

Unknown

Global Post-Market Registry Using Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue (OPEN WATER)

BPH

Australia, Lebanon, United Kingdom, Germany, New Zealand
Medi-Tate Ltd.

Terminated

Study to Assess the Efficacy, Safety and Tolerability of (iTind)

BPH

United Kingdom
United Therapeutics

Withdrawn

Dose Escalation, MTD, Safety and PK Study of a Single Dose SC Injection of TransCon PEG Treprostinil in Healthy Male Volunteers

PAH

United States
Focus Medical, LLC

Completed

Evaluation of the Effectiveness of the PiQo4 System for Reduction of Infra-orbital Pigmentation

POH

United States
University of North Carolina, Chapel Hill
BTG International Inc.

Completed

LC Bead LUMI for Prostatic Artery Embolization

BPH

United States
King's College London
South London and Maudsley NHS Foundation Trust

Completed

CBT Plus SMC Compared to SMC for Persistent Physical Symptoms in Secondary Care (PRINCE) (PRINCE)

Persistent Physical Symptoms (PPS)

United Kingdom
Medi-Tate Ltd.

Completed

Study to Assess the Efficacy of Medi-Tate iTind Device

Benign Prostatic Hyperplasia (BPH)

Spain, Belgium, Italy, Switzerland, United Kingdom
Boston Scientific Corporation

Terminated

Minimally Invasive Prostatic Vapor Ablation for the Treatment of BPH in Large Prostates (Rezūm XL) (Rezūm XL)

BPH | BPH With Urinary Obstruction | BPH With Urinary Obstruction With Other Lower Urinary Tract Symptoms

United States, Australia
Alnylam Pharmaceuticals

Completed

A Phase 1/2 Study of an Investigational Drug, ALN-CC5, in Healthy Adult Volunteers and Patients With PNH

Paroxysmal Nocturnal Hemoglobinuria (PNH)

Spain, United Kingdom
Pfizer's Upjohn has merged with Mylan to form Viatris...

Terminated

Study To Investigate Safety And Efficacy Of Sildenafil In The Newborns With Persistent Pulmonary Hypertension (PPHN)

Persistent Pulmonary Hypertension of the Newborn | Hypoxic Respiratory Failure | PPHN

United Kingdom
Benaroya Research Institute
Virginia Mason Hospital/Medical Center

Unknown

Optimizing Pain Control in Transurethral Resection of the Prostate

Pain | BPH With Urinary Obstruction | BPH With Urinary Obstruction With Other Lower Urinary Tract Symptoms

United States
Ohio State University

Completed

ROTEM® Obstetric Hemorrhage Pilot Study

High Risk Postpartum Hemorrhage (PPH)

United States
Hackensack Meridian Health

Completed

Accurate Display of Postpartum Hemorrhage Using Triton (ADOPT) (ADOPT)

Post-partum Hemorrhage (PPH)

United States
BE Technologies Inc
Urology of Virginia

Completed

BE Technologies Mobile Uroflowmetry Validation Study

Overactive Bladder | Lower Urinary Tract Symptoms | Urinary Incontinence, Urge | Overactive Bladder Syndrome | BPH | Urinary Obstruction | BPH With Urinary Obstruction With Other Lower Urinary Tract Symptoms | BPH Without Urinary Obstruction | BPH Without Urinary Obstruction With Other Lower Urinary...

United States
Actelion

Active, not recruiting

Clinical Study to Compare the Efficacy and Safety of Macitentan and Tadalafil Monotherapies With the Corresponding Fixed-dose Combination Therapy in Subjects With Pulmonary Arterial Hypertension (PAH) (A DUE)

Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH)

United States, Japan, Taiwan, Turkey, Canada, China, Germany, Spain, Italy, Malaysia, Hungary, Russian Federation, Brazil, Australia, Bulgaria, Czechia, Mexico, Poland, South Africa
University of North Carolina, Chapel Hill
Terumo Medical Corporation

Terminated

Prostatic Artery Embolization vs Medication for Benign Prostatic Hyperplasia

Prostatic Hyperplasia | BPH | Enlarged Prostate (BPH)

United States
University of Wisconsin, Madison
Wisconsin Partnership Program

Recruiting

US Imaging for the Assessment of LUTS

Lower Urinary Tract Symptoms | BPH

United States
LycoRed Ltd.

Completed

Effects of LycoComfort™ Supplementation on Symptoms Associated With Lower Urinary Tract Symptoms (LUTS)

Lower Urinary Tract Symptoms | BPH

United States
Alexion Pharmaceuticals
Achillion, a wholly owned subsidiary of Alexion

Completed

Study of Danicopan in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH)

Paroxysmal Nocturnal Hemoglobinuria (PNH)

United Kingdom, New Zealand, Korea, Republic of, Italy
Trace Minerals
Citruslabs

Active, not recruiting

A Clinical Trial to Evaluate the Efficacy of ConcenTrace to Buffer pH Levels Within the Body.

pH

United States
NeoTract, Inc.

Recruiting

Investigating Medication vs. Prostatic Urethral Lift: Assessment and Comparison of Therapies for BPH (IMPACT)

BPH

United States
The Cleveland Clinic

Withdrawn

Biomarkers in Pulmonary Arterial Hypertension Treated With Nilotinib

PAH

United States
Olympus Corporation of the Americas

Recruiting

A Randomized, International Study to Assess the Safety of iTind Compared to UroLift (MT-08)

Benign Prostatic Hyperplasia (BPH)

United States, United Kingdom, Canada
Alexion Pharmaceuticals, Inc.
Achillion, a wholly owned subsidiary of Alexion

Completed

Study of Danicopan in Participants With Paroxysmal Nocturnal Hemoglobinuria With Inadequate Response to Eculizumab (PNH)

Paroxysmal Nocturnal Hemoglobinuria (PNH)

United Kingdom, United States, Italy
Novartis Pharmaceuticals

Completed

Exploratory Phase II Study of INC424 Patients With Primary Myelofibrosis (PMF) or Post Polycythaemia Myelofibrosis (PPV MF) or Post Essential Thrombocythaemia Myelofibrosis (PET-MF) (MACS2030)

Primary Myelofibrosis (PMF) | Post Polycythaemia Myelofibrosis (PPV MF) | Post Essential Thrombocythaemia Myelofibrosis (PET-MF)

United Kingdom
BioCryst Pharmaceuticals

Terminated

A Long Term Safety Study of BCX9930 in Subjects With Paroxysmal Nocturnal Hemoglobinuria (PNH)

Paroxysmal Nocturnal Hemoglobinuria | PNH

United Kingdom, Austria, South Africa
Northwestern University

Recruiting

Intra-operative Loop Diuretics to Improve Same-day Discharge Rates After HoLEP

Hematuria | BPH | Same Day Discharge | BPH With Urinary Obstruction

United States
Robert W. Alexander, MD, FICS
Terry, Glenn C., M.D.

Withdrawn

Use of Autologous Adipose-Derived Stem/Stromal Cells (AD-cSVF) in Symptomatic Benign Prostate Hypertrophy (SVF-BPN)

Nocturia | BPH | BPH With Urinary Obstruction | Prostatism | Prostate Inflammation

United States
Massachusetts General Hospital

Recruiting

Effect of Theophylline in Pseudohypoparathyroidism

PHP Ia | PHP IB | Php1C

United States
Apellis Pharmaceuticals, Inc.

Active, not recruiting

Pegcetacoplan Long Term Safety and Efficacy Extension Study

PNH

United States, France, Germany, Canada, United Kingdom, Belgium, Hong Kong, Japan, Singapore, Thailand, Russian Federation, Serbia, Australia, Bulgaria, Spain, Malaysia, Korea, Republic of, Colombia, Mexico, Peru, Philippines
Apellis Pharmaceuticals, Inc.

Recruiting

A Study of Pegcetacoplan in Pediatric Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)

Paroxysmal Nocturnal Hemoglobinuria (PNH) | Paroxysmal Hemoglobinuria

Malaysia, United States, Czechia, France, Netherlands, Serbia, Spain, Thailand, United Kingdom
BioCryst Pharmaceuticals

Terminated

BCX9930 for Treatment of PNH in Subjects With Inadequate Response to C5 Inhibitor Therapy (REDEEM-1)

Paroxysmal Nocturnal Hemoglobinuria (PNH)

United Kingdom, Hungary, France, Italy, Spain
Imago BioSciences, Inc., a subsidiary of Merck...

Completed

Bomedemstat (IMG-7289/MK-3543) in Participants With Myelofibrosis (IMG-7289-CTP-102/MK-3543-002)

Myelofibrosis | Primary Myelofibrosis (PMF) | Post-polycythemia Vera Myelofibrosis (PPV-MF) | Post-essential Thrombocythemia Myelofibrosis (PET-MF)

Germany, United States, Australia, Italy, United Kingdom
Alexion Pharmaceuticals

Completed

Paroxysmal Nocturnal Hemoglobinuria Human Anti-Human Antibodies Study

Paroxysmal Nocturnal Hemoglobinuria | PNH

Australia, France, United Kingdom, Belgium, Germany, Netherlands, Ireland, United States, Switzerland, Italy
Alexion Pharmaceuticals

Terminated

Safety and Pharmacokinetics of TT30 in Subjects With Paroxysmal Nocturnal Hemoglobinuria (PNH)

Paroxysmal Nocturnal Hemoglobinuria (PNH)

United States, Czech Republic, Italy, Poland, United Kingdom
PROCEPT BioRobotics

Completed

Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue (WATER) (WATER)

Benign Prostatic Hyperplasia (BPH)

United States, Australia, United Kingdom, New Zealand
Vanderbilt University Medical Center

Terminated

Assessing Normal Multichannel Intraluminal Impedance (MII)-pH Parameters for Today's Population

Identify Normal MII-pH Parameters

United States
ProVerum Medical

Recruiting

ProVIDE II Bridging Study

BPH With Symptomatic Lower Urinary Tract Symptoms

United States
RightBio Metrics

Unknown

Product Validation Study of RightSpot Infant pH Indicator for Rapid Bedside Verification of Proper Nasogastric (NG) Tube Placement in Newborn Intensive Care (NICU) Patients

Establish Normative pH Values in Neonates

United States
Boehringer Ingelheim

Completed

A Study to Test How Effective and Safe Different Doses of BI 655130 Are in Patients With a Moderate to Severe Form of the Skin Disease Palmoplantar Pustulosis

Palmoplantar Pustulosis (PPP)

United Kingdom, Korea, Republic of, United States, Canada, Belgium, Australia, Taiwan, Japan, France, Germany, Russian Federation, Hungary, Netherlands, Czechia, Poland
Ra Pharmaceuticals

Completed

Phase 2 Safety and Efficacy Study of Zilucoplan (RA101495) to Treat PNH Patients

Paroxysmal Nocturnal Hemoglobinuria (PNH)

United Kingdom, Australia, Canada, Denmark, Finland, Germany, Hungary, New Zealand
University of Kansas Medical Center

Enrolling by invitation

SOLTIVE™ Laser Enucleation for Treatment of Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia | BPH

United States
Brooklyn Urology Research Group
American Medical Systems; Richard Wolf Medical Instruments Corporation (RWMIC)

Completed

Phase 4 Study of Greenlight XPS Laser Versus BiVAP Saline Vaporization of the Prostate in Men With Symptomatic Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia (BPH)

United States
Galderma R&D

Completed

Phase 3 Papulopustular Rosacea Study

Papulopustular Rosacea (PPR)

United States, Canada
United Therapeutics

Completed

Safety, Tolerability, and Pharmacokinetics of Oral Treprostinil in Pediatric PAH Patients Aged 7 to 17 Years

PAH

United States
The Cleveland Clinic

Completed

Pulmonary Hypertension and Imatinib

PAH

United States
Alexion

Active, not recruiting

Study of the Oral Factor D (FD) Inhibitor ALXN2050 in PNH Patients as Monotherapy

Paroxysmal Nocturnal Hemoglobinuria (PNH)

United Kingdom, Italy, Canada, Korea, Republic of, New Zealand, Spain, Turkey
National Heart, Lung, and Blood Institute (NHLBI)
Zymedi, Co., Ltd.

Recruiting

Study of Intravenous ZMA001 in Healthy Subjects

Pulmonary Arterial Hypertension PAH

United States
Alexion Pharmaceuticals

Completed

Open-label, Multiple Ascending Dose Study of Ravulizumab (ALXN1210) in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH)

Paroxysmal Nocturnal Hemoglobinuria | PNH

Korea, Republic of, Canada, France, Germany, Spain, Taiwan, United Kingdom

Clinical Trials on PPH in United Kingdom

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Gambia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations